ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1910

Regulation of Microrna 223 Expression in a Gouty Arthritis

Gianina Statache1, Ashleigh-Ann Rainey1, Seth Masters2, Andra Balanescu3, Iain B. McInnes4 and Mariola Kurowska-Stolarska5, 1Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom, 2Immunology Research Centre, Trinity College Dublin, Dublin, United Kingdom, 3Internal Medicine and Rheumatology, University of Medicine and Pharmacy, Bucharest, Romania, 4University of Glasgow, Glasgow, United Kingdom, 5Institute of Infection,Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: cytokines, monocytes and uric acid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Metabolic and Crystal Arthropathies

Session Type: Abstract Submissions (ACR)

Background/Purpose: Gout is an inflammatory chronic disease caused by deposition of uric acid crystals in the joint and connective tissues causing pain and disability. Current data suggest that gout is mediated by IL-1b that is produced due to the activation of the inflammasome pathway by uric acid crystals.  In addition, neutrophil influx in the joint is the key initiator of a gout flare.  miR-223 has been identified as a masterswitch molecule limiting neutrophil activation. In addition, we showed previously that this miR negatively regulates NLRP3 (an inflammasome component) and IL-1b production in human macrophages. To investigate miR-223 expression and regulation in monocytes and neutrophils of gout patients. 

Methods:

CD14+ cells and neutrophils were isolated from gout patients (n=10) and healthy donors (n=6) peripheral blood using CD14 microbeads and polylymphoprep gradient buffer, respectively. CD14+ from healthy donors were stimulated with LPS (10 ng/ml) IL-1beta (100-10ng/ml), IL-6 (100 ng/ml), TNF alpha (10-100ng/ml) or monosodium urate crystals MSU (1mg-1ug/ml) for different time points (24-72h). Cells were harvested and miRNA extracted. Expression of miR-223 and endogenous control snRNA U1 was assessed by qPCR. 

Results:

miR-223 expression in peripheral blood monocytes of patients with  chronic gout was lower compared to healthy controls.  This suggest that overproduction of IL-1b in chronic disease might be partially mediated by low levels of miR-223. In vitro studies revealed that MSU, IL-1b, TNFa and IL-6 significantly inhibited miR-223 expression in monocytes in all time points (24-72h). In contrast, IL-10 strongly increased miR-223 expression. Interestingly, the levels of miR-223 in peripheral blood neutrophils were higher in gout patients compared to healthy controls 

Conclusion:

A decrease in miR-223 expression in monocytes of chronic gout patients may contribute to uric acid crystals induced inflammasome activation and chronicity of disease. Upregulation of miR-223 expression in gout neutrophils may reflect the activation of mechanisms that limits neutrophils activation and lead to the resolution of gout flares.


Disclosure:

G. Statache,
None;

A. A. Rainey,
None;

S. Masters,
None;

A. Balanescu,
None;

I. B. McInnes,
None;

M. Kurowska-Stolarska,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/regulation-of-microrna-223-expression-in-a-gouty-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology